Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:08 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Venrock Healthcare Capital Partners II L.P. | 6,502,840 7.5% | 2,500,000 (+62.46%) | View |
| 2020-02-14 3:19 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Lion Point Capital LP | 6,374,740 7.7% | 6,374,740 (New Position) | View |
| 2020-02-14 10:07 am Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Avoro Capital Advisors LLC | 10,405,250 9.99% | 10,405,250 (New Position) | View |
| 2020-02-14 06:27 am Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Bain Capital Life Sciences Fund L.P. | 5,390,922 6.2% | 816,430 (+17.85%) | View |
| 2020-02-07 10:38 am Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | JENNISON ASSOCIATES LLC | 0 0% | -4,554,759 (Position Closed) | View |
| 2020-02-06 3:05 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | PRUDENTIAL FINANCIAL INC PRU | 1,580 5% | -4,555,309 (-99.97%) | View |
| 2020-01-27 4:59 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Granite Point Capital Management L.P. | 2,700,000 3.1% | -1,559,367 (-36.61%) | View |
| 2019-12-20 1:59 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,800,000 5.55% | 4,800,000 (New Position) | View |
| 2019-12-13 5:12 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Boxer Capital LLC | 4,800,000 6% | 4,800,000 (New Position) | View |
| 2019-10-07 4:05 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Venrock Healthcare Capital Partners II L.P. | 4,002,840 7.6% | 4,002,840 (New Position) | View |